Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00034216 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Collection of Blood From Patients With Cancer

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 350 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. New version filed on ClinicalTrials.gov
  3. 32 versions Re-verified since Jul 9, 2025, no change to tracked fieldsv317-v348
  4. Study Status, Contacts/Locationsv316
  5. 15 versions Re-verified since Nov 28, 2024, no change to tracked fieldsv301-v315
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
National Cancer Institute (NCI)
961 trials monitored
See 67 trials at risk
Breast Cancer
5,213 trials monitored
See 266 trials at risk
Lung Cancer
4,057 trials monitored
See 215 trials at risk
Colorectal Cancer
2,920 trials monitored
See 131 trials at risk
and 2 more diseases
This study will collect blood from patients with cancer to study the level of cells which decrease the immune response (suppressor cells) before and after chemotherapy. Patients 18 years of age and older with cancer may participate. This study does not involve treatment. Participants will have about 50 ml (3 tablespoonfuls) of blood drawn. Depending on their condition, patients may be invited to enroll in a clinical research study involving chemotherapy, radiotherapy, or surgery. Additional 40-ml blood samples may be drawn during the course of treatment. ...
Trial Details
NCT Number NCT00034216
Lead Sponsor National Cancer Institute (NCI)
Conditions Prostate Cancer, Breast Cancer, Colon Cancer, Lung Cancer, Liver Cancer
Enrollment 1,750 participants
Start Date
Updated on ClinicalTrials.gov